Literature DB >> 29710548

Diosmin and crocin alleviate nephropathy in metabolic syndrome rat model: Effect on oxidative stress and low grade inflammation.

Rania El-Fawal1, Hassan M El Fayoumi2, Mona F Mahmoud3.   

Abstract

Nephropathy is a serious complication of metabolic syndrome (MS), a global epidemic disorder. This study was undertaken to investigate the actions of diosmin and crocin, two natural ingredients, on diabetic nephropathy in a rat model of MS and the underlying mechanism(s). Metabolic syndrome was induced by the addition of 10% fructose to drinking water and placing the rats on high-salt diet for 16 weeks. Diosmin and Crocin were orally administrated daily for 10 weeks starting at week 6. At the end of study, arterial blood pressure was non-invasively recorded. Urine, serum and kidneys were collected for renal function, oxidative stress, glycemic parameters, inflammatory markers and histological analysis. Both Diosmin and Crocin improved insulin resistance, decreased blood pressure, uric acid, lipoproteins and blocked diabetic nephropathy as indicated by reduction of albumin excretion rate and albumin/creatinine ratio. They alleviated the impaired filtration in MS as indicated by increased creatinine clearance. They also ameliorated oxidative stress and the low-grade 1inflammation as indicated by reduction of serum TNF-α and inflammatory cells. These observations suggest that both Diosmin and Crocin alleviate metabolic syndrome and the associated nephropathy in rats, possibly, through inhibiting oxidative stress and inflammation.
Copyright © 2018 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Crocin; Diosmin; Metabolic syndrome; Nephropathy

Mesh:

Substances:

Year:  2018        PMID: 29710548     DOI: 10.1016/j.biopha.2018.03.162

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  6 in total

1.  Effects of diosmin and crocin on metabolic syndrome-associated cardio-vascular complications in rats.

Authors:  Rania El-Fawal; Hassan M El Fayoumi; Mona F Mahmoud
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-07-27       Impact factor: 3.000

2.  Crocin protects the renal tubular epithelial cells against high glucose-induced injury and oxidative stress via regulation of the SIRT1/Nrf2 pathway.

Authors:  Jichen Zhang; Xuemei Zhao; Hongling Zhu; Jingnan Wang; Junhua Ma; Mingjun Gu
Journal:  Iran J Basic Med Sci       Date:  2022-02       Impact factor: 2.532

3.  The effect of crocin supplementation on glycemic control, insulin resistance and active AMPK levels in patients with type 2 diabetes: a pilot study.

Authors:  Vahideh Behrouz; Ali Dastkhosh; Mehdi Hedayati; Meghdad Sedaghat; Maryam Sharafkhah; Golbon Sohrab
Journal:  Diabetol Metab Syndr       Date:  2020-07-09       Impact factor: 3.320

4.  The potential beneficial effects of sildenafil and diosmin in experimentally-induced gastric ulcer in rats.

Authors:  Alaa E El-Sisi; Samia S Sokar; Sally E Abu-Risha; Doaa Y Khira
Journal:  Heliyon       Date:  2020-08-22

5.  Combating atherosclerosis with targeted Diosmin nanoparticles-treated experimental diabetes.

Authors:  Hendawy Om; Mehrez E El-Naggar; Mona El-Banna; Moustafa M G Fouda; Sarah I Othman; Ahmed A Allam; Osama M Morsy
Journal:  Invest New Drugs       Date:  2020-02-11       Impact factor: 3.850

6.  Diosmin mitigates high glucose-induced endoplasmic reticulum stress through PI3K/AKT pathway in HK-2 cells.

Authors:  Jiuhong Deng; Chao Zheng; Zhou Hua; Haideng Ci; Guiying Wang; Lijing Chen
Journal:  BMC Complement Med Ther       Date:  2022-04-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.